Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Mian

Showing results (51-60 of 96) with videos related to

Pageof 10
Sort By:
BMC Emergency Medicine|March 21, 2026
Factors associated with avoidable non-urgent emergency department visits in South Tyrol (Italy): a multicentre cross-sectional studyDietmar Ausserhofer, Arian Zaboli, Angelika Mahlknecht, et al.
Annals of Hematology|April 23, 2016
Bendamustine plus rituximab versus R-CHOP as first-line treatment for patients with indolent non-Hodgkin's lymphoma: evidence from a multicenter, retrospective studyPatrizia Mondello, Normann Steiner, Wolfgang Willenbacher, et al.
Prehospital Emergency Care|April 20, 2017
Evaluation of the Implementation of the Trauma Triage and Destination Plan on the Field Triage of Injured Patients in North CarolinaJane H Brice, Frances S Shofer, Christopher Cowden, et al.
Hematological Oncology|June 15, 2011
Del(13q14.3) length matters: an integrated analysis of genomic, fluorescence in situ hybridization and clinical data in 169 chronic lymphocytic leukaemia patients with 13q deletion alone or a normal karyotypeMichael Mian, Andrea Rinaldi, Afua Adjeiwaa Mensah, et al.
Internal and Emergency Medicine|August 6, 2024
Assessing triage efficiency in Italy: a comparative study using simulated cases among nursesArian Zaboli, Francesco Brigo, Alessandro Cipriano, et al.
British Journal of Haematology|November 28, 2018
Phase II trial to investigate efficacy and safety of bendamustine, dexamethasone and thalidomide in relapsed or refractory multiple myeloma patients after treatment with lenalidomide and bortezomibMichael Mian, Norbert Pescosta, Stefania Badiali, et al.
British Journal of Haematology|December 17, 2013
Genome-wide DNA profiling identifies clonal heterogeneity in marginal zone lymphomasMichael Mian, Ivo Kwee, Andrea Rinaldi, et al.
Rheumatology (Oxford, England)|December 7, 2023
Hospitalization, disease severity and mortality rates of patients with inflammatory rheumatic diseases as compared with the normal population in the second wave of SARS-CoV-2 infectionsGloria Dallagiacoma, Christian X Weichenberger, Bernd Raffeiner, et al.
Anticancer Research|March 16, 2016
Bortezomib, Thalidomide and Lenalidomide: Have They Really Changed the Outcome of Multiple Myeloma?Michael Mian, Martina Tinelli, Elena DE March, et al.
Frontiers in Psychology|May 22, 2023
Relationship between depression, anxiety, stress, and SARS-CoV-2 infection: a longitudinal studyDietmar Ausserhofer, Angelika Mahlknecht, Adolf Engl, et al.
Pageof 10

Showing results (51-60 of 96) with videos related to

Sort By:
Pageof 10
BMC Emergency Medicine|March 21, 2026
Factors associated with avoidable non-urgent emergency department visits in South Tyrol (Italy): a multicentre cross-sectional studyDietmar Ausserhofer, Arian Zaboli, Angelika Mahlknecht, et al.
Annals of Hematology|April 23, 2016
Bendamustine plus rituximab versus R-CHOP as first-line treatment for patients with indolent non-Hodgkin's lymphoma: evidence from a multicenter, retrospective studyPatrizia Mondello, Normann Steiner, Wolfgang Willenbacher, et al.
Prehospital Emergency Care|April 20, 2017
Evaluation of the Implementation of the Trauma Triage and Destination Plan on the Field Triage of Injured Patients in North CarolinaJane H Brice, Frances S Shofer, Christopher Cowden, et al.
Hematological Oncology|June 15, 2011
Del(13q14.3) length matters: an integrated analysis of genomic, fluorescence in situ hybridization and clinical data in 169 chronic lymphocytic leukaemia patients with 13q deletion alone or a normal karyotypeMichael Mian, Andrea Rinaldi, Afua Adjeiwaa Mensah, et al.
Internal and Emergency Medicine|August 6, 2024
Assessing triage efficiency in Italy: a comparative study using simulated cases among nursesArian Zaboli, Francesco Brigo, Alessandro Cipriano, et al.
British Journal of Haematology|November 28, 2018
Phase II trial to investigate efficacy and safety of bendamustine, dexamethasone and thalidomide in relapsed or refractory multiple myeloma patients after treatment with lenalidomide and bortezomibMichael Mian, Norbert Pescosta, Stefania Badiali, et al.
British Journal of Haematology|December 17, 2013
Genome-wide DNA profiling identifies clonal heterogeneity in marginal zone lymphomasMichael Mian, Ivo Kwee, Andrea Rinaldi, et al.
Rheumatology (Oxford, England)|December 7, 2023
Hospitalization, disease severity and mortality rates of patients with inflammatory rheumatic diseases as compared with the normal population in the second wave of SARS-CoV-2 infectionsGloria Dallagiacoma, Christian X Weichenberger, Bernd Raffeiner, et al.
Anticancer Research|March 16, 2016
Bortezomib, Thalidomide and Lenalidomide: Have They Really Changed the Outcome of Multiple Myeloma?Michael Mian, Martina Tinelli, Elena DE March, et al.
Frontiers in Psychology|May 22, 2023
Relationship between depression, anxiety, stress, and SARS-CoV-2 infection: a longitudinal studyDietmar Ausserhofer, Angelika Mahlknecht, Adolf Engl, et al.
Pageof 10